The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Inflammatory markers at baseline (C1) and cycle 3 (C3) and their association with clinical outcomes in urothelial cancer patients (pts) treated with immunotherapy (IO).
 
Julie M. Shabto
No Relationships to Disclose
 
Dylan J Martini
No Relationships to Disclose
 
Yuan Liu
No Relationships to Disclose
 
Deepak Ravindranathan
No Relationships to Disclose
 
Meredith R Kline
No Relationships to Disclose
 
Elise Hitron
No Relationships to Disclose
 
Greta Russler
No Relationships to Disclose
 
Sarah Caulfield
No Relationships to Disclose
 
Haydn Kissick
No Relationships to Disclose
 
Mehrdad Alemozaffar
No Relationships to Disclose
 
Kenneth Ogan
No Relationships to Disclose
 
Wayne Harris
No Relationships to Disclose
 
Omer Kucuk
No Relationships to Disclose
 
Bradley Curtis Carthon
Consulting or Advisory Role - Astellas Medivation; Blue Earth Diagnostics; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Viraj A. Master
No Relationships to Disclose
 
Mehmet Asim Bilen
Consulting or Advisory Role - Exelixis; Nektar; Sanofi
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Incyte (Inst); Nektar (Inst); Peleton (Inst); Pfizer (Inst); Seagen (Inst); Tricon Pharmaceuticals (Inst)